Skip to content

Study · Measured the body's own peptide · 2024

3 results

Evaluation of vascular peroxidase 1, humanin, MOTS-c and miR-200c expression levels in untreated preeclampsia patients.

Coskun E, Ekmekci OB, Gungor Z, Tuten A, Oncul M, Hamzaoğlu K, Gok K, Ekmekci H

Molecular biology reports20 Dec 2024Cited by 3 (Europe PMC)

PMID39704971 (opens in a new tab)DOI10.1007/s11033-024-10148-w (opens in a new tab)PepBankPUB-39704971
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Natural levels measured3

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In untreated preeclamptic pregnancies, MOTS‑c levels were significantly reduced compared with the control group.

    In plain wordsIn untreated preeclampsia, the body's own MOTS‑c levels were lower than in the control group.

    Peptide
    MOTS-c
    Outcome
    DecreaseMOTS-c level in preeclampsia
    Study

    n: not reported in source

    Comparator
    Control group
    Outcome group
    Aging markers · Reproductive and sexual health

    Source sentences

    Summary
    whereas MOTS-c levels were significantly reduced (p < 0.05).
    1 context sentence
    Summary · context
    In this study, blood samples were collected from preeclamptic patients presenting to the clinic prior to the initiation of treatment.

    This result measures the body's own MOTS-c. Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelObservational studyOther

    In untreated preeclamptic pregnancies, humanin levels did not differ significantly from the control group.

    In plain wordsIn untreated preeclampsia, the body's own humanin levels did not differ significantly from controls.

    Peptide
    Humanin
    Outcome
    No significant changeHumanin level in preeclampsia
    Study

    n: not reported in source

    Comparator
    Control group
    Outcome group
    Mitochondrial function · Reproductive and sexual health

    Source sentences

    Summary
    No significant difference was observed in humanin levels between the two groups.
    1 context sentence
    Summary · context
    In this study, blood samples were collected from preeclamptic patients presenting to the clinic prior to the initiation of treatment.

    This result measures the body's own Humanin. Nobody was given the peptide. It is not evidence about taking it.

  3. 03HumanEndogenous levelObservational studyOther

    In untreated preeclamptic pregnancies, humanin levels correlated positively with endoglin levels.

    In plain wordsIn untreated preeclampsia, higher natural humanin levels were linked to higher endoglin levels.

    Peptide
    Humanin
    Outcome
    Not applicableCorrelation of humanin with endoglin
    Study

    n: not reported in source

    Outcome group
    Mitochondrial function · Reproductive and sexual health

    Measurements

    Correlation r
    0.421 r
    humanin with endoglin, preeclamptic group

    Source sentences

    Summary
    A positive correlation was identified between endoglin levels and VPO1 (r = 0.943, p < 0.001), humanin (r = 0.421, p < 0.01)
    1 context sentence
    Summary · context
    In this study, blood samples were collected from preeclamptic patients presenting to the clinic prior to the initiation of treatment.

    This result measures the body's own Humanin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 4 to 18Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 15 times, first on 13 Oct 2026, 21:44 UTC. The status did not change between them.

    Study results updated

  2. Version 3

    13 Oct 2026, 16:31 UTC

    Study data updated · source update from Europe PMC

  3. Version 2

    10 Oct 2026, 08:19 UTC

    Study results updated

  4. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.